447 related articles for article (PubMed ID: 28991706)
1. Apixaban for the treatment of cerebral venous thrombosis: A case series.
Rao SK; Ibrahim M; Hanni CM; Suchdev K; Parker D; Rajamani K; Mohamed W
J Neurol Sci; 2017 Oct; 381():318-320. PubMed ID: 28991706
[TBL] [Abstract][Full Text] [Related]
2. Direct Oral Anticoagulants for the Treatment of Cerebral Venous Thrombosis.
Lurkin A; Derex L; Fambrini A; Bertoletti L; Epinat M; Mismetti P; Dargaud Y
Cerebrovasc Dis; 2019; 48(1-2):32-37. PubMed ID: 31480062
[TBL] [Abstract][Full Text] [Related]
3. Direct oral anticoagulants in rare venous thrombosis.
Finazzi G; Ageno W
Intern Emerg Med; 2016 Mar; 11(2):167-70. PubMed ID: 26875179
[TBL] [Abstract][Full Text] [Related]
4. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study.
Yaghi S; Shu L; Bakradze E; Salehi Omran S; Giles JA; Amar JY; Henninger N; Elnazeir M; Liberman AL; Moncrieffe K; Lu J; Sharma R; Cheng Y; Zubair AS; Simpkins AN; Li GT; Kung JC; Perez D; Heldner M; Scutelnic A; Seiffge D; Siepen B; Rothstein A; Khazaal O; Do D; Kasab SA; Rahman LA; Mistry EA; Kerrigan D; Lafever H; Nguyen TN; Klein P; Aparicio H; Frontera J; Kuohn L; Agarwal S; Stretz C; Kala N; El Jamal S; Chang A; Cutting S; Xiao H; de Havenon A; Muddasani V; Wu T; Wilson D; Nouh A; Asad SD; Qureshi A; Moore J; Khatri P; Aziz Y; Casteigne B; Khan M; Cheng Y; Mac Grory B; Weiss M; Ryan D; Vedovati MC; Paciaroni M; Siegler JE; Kamen S; Yu S; Leon Guerrero CR; Atallah E; De Marchis GM; Brehm A; Dittrich T; Psychogios M; Alvarado-Dyer R; Kass-Hout T; Prabhakaran S; Honda T; Liebeskind DS; Furie K
Stroke; 2022 Mar; 53(3):728-738. PubMed ID: 35143325
[TBL] [Abstract][Full Text] [Related]
5. The use of direct oral anticoagulants in 56 patients with antiphospholipid syndrome.
Malec K; Góralczyk T; Undas A
Thromb Res; 2017 Apr; 152():93-97. PubMed ID: 27989533
[TBL] [Abstract][Full Text] [Related]
6. Safety and efficacy of Direct Oral Anticoagulants in cerebral venous thrombosis: A meta-analysis.
Nepal G; Kharel S; Bhagat R; Ka Shing Y; Ariel Coghlan M; Poudyal P; Ojha R; Sunder Shrestha G
Acta Neurol Scand; 2022 Jan; 145(1):10-23. PubMed ID: 34287841
[TBL] [Abstract][Full Text] [Related]
7. Safety and Efficacy of Dabigatran Etexilate vs Dose-Adjusted Warfarin in Patients With Cerebral Venous Thrombosis: A Randomized Clinical Trial.
Ferro JM; Coutinho JM; Dentali F; Kobayashi A; Alasheev A; Canhão P; Karpov D; Nagel S; Posthuma L; Roriz JM; Caria J; Frässdorf M; Huisman H; Reilly P; Diener HC;
JAMA Neurol; 2019 Dec; 76(12):1457-1465. PubMed ID: 31479105
[TBL] [Abstract][Full Text] [Related]
8. Cerebral Venous Thrombosis: Current and Newer Anticoagulant Treatment Options.
Patel SI; Obeid H; Matti L; Ramakrishna H; Shamoun FE
Neurologist; 2015 Nov; 20(5):80-8. PubMed ID: 26566039
[TBL] [Abstract][Full Text] [Related]
9. Rivaroxaban for the treatment of cerebral venous thrombosis: a single-center experience.
Bajko Z; Maier S; Motataianu A; Filep RC; Stoian A; Andone S; Balasa R
Acta Neurol Belg; 2022 Feb; 122(1):105-111. PubMed ID: 33733345
[TBL] [Abstract][Full Text] [Related]
10. Is it safe to treat cerebral venous thrombosis with oral rivaroxaban without heparin? A preliminary study from 20 patients.
Shankar Iyer R; Tcr R; Akhtar S; Muthukalathi K; Kumar P; Muthukumar K
Clin Neurol Neurosurg; 2018 Dec; 175():108-111. PubMed ID: 30396036
[TBL] [Abstract][Full Text] [Related]
11. Novel oral anticoagulants for stroke prevention in atrial fibrillation: focus on apixaban.
Potpara TS; Polovina MM; Licina MM; Stojanovic RM; Prostran MS; Lip GY
Adv Ther; 2012 Jun; 29(6):491-507. PubMed ID: 22684583
[TBL] [Abstract][Full Text] [Related]
12. Preliminary findings regarding the use of direct oral anticoagulants in cerebral venous thrombosis.
Hsu A; Mistry H; Lala N; Reagan JL
Clin Neurol Neurosurg; 2020 Nov; 198():106204. PubMed ID: 32937276
[TBL] [Abstract][Full Text] [Related]
13. Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation.
Lip GY; Larsen TB; Skjøth F; Rasmussen LH
J Am Coll Cardiol; 2012 Aug; 60(8):738-46. PubMed ID: 22575324
[TBL] [Abstract][Full Text] [Related]
14. Novel oral anticoagulants in the treatment of cerebral venous thrombosis.
Feher G; Illes Z; Komoly S; Hargroves D
Int Angiol; 2016 Aug; 35(4):365-8. PubMed ID: 25994451
[TBL] [Abstract][Full Text] [Related]
15. Non-vitamin K antagonist oral anticoagulants in cardiovascular disease management: evidence and unanswered questions.
Cheng JW; Barillari G
J Clin Pharm Ther; 2014 Apr; 39(2):118-35. PubMed ID: 24383983
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study.
Nielsen PB; Skjøth F; Søgaard M; Kjældgaard JN; Lip GY; Larsen TB
BMJ; 2017 Feb; 356():j510. PubMed ID: 28188243
[No Abstract] [Full Text] [Related]
17. Non-Vitamin K Antagonist Oral Anticoagulants for the Treatment of Cerebral Venous Sinus Thrombosis: a Retrospective, Matched Cohort Analysis.
Giles JA; Balasetti VKS; Zazulia AR
Neurocrit Care; 2021 Dec; 35(3):783-788. PubMed ID: 34046861
[TBL] [Abstract][Full Text] [Related]
18. Apixaban for the Treatment of Japanese Subjects With Acute Venous Thromboembolism (AMPLIFY-J Study).
Nakamura M; Nishikawa M; Komuro I; Kitajima I; Uetsuka Y; Yamagami T; Minamiguchi H; Yoshimatsu R; Tanabe K; Matsuoka N; Kanmuri K; Ogawa H
Circ J; 2015; 79(6):1230-6. PubMed ID: 25912695
[TBL] [Abstract][Full Text] [Related]
19. Apixaban versus Warfarin for the Prevention of Periprocedural Cerebral Thromboembolism in Atrial Fibrillation Ablation: Multicenter Prospective Randomized Study.
Kuwahara T; Abe M; Yamaki M; Fujieda H; Abe Y; Hashimoto K; Ishiba M; Sakai H; Hishikari K; Takigawa M; Okubo K; Takagi K; Tanaka Y; Nakajima J; Takahashi A
J Cardiovasc Electrophysiol; 2016 May; 27(5):549-54. PubMed ID: 26766541
[TBL] [Abstract][Full Text] [Related]
20. Bleeding with dabigatran, rivaroxaban, apixaban. No antidote, and little clinical experience.
Prescrire Int; 2013 Jun; 22(139):155-9. PubMed ID: 23866358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
